Walleye Capital LLC Syros Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

  • $54.3 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$0.69 - $1.21 $38,700 - $67,866
-56,088 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.02 - $3.8 $45,989 - $171,334
45,088 Added 409.89%
56,088 $67,000
Q4 2021

Mar 03, 2022
SELL
$3.26 - $4.66 $72,460 - $103,577
-22,227 Reduced 66.89%
11,000 $35,000
Q3 2021

Nov 15, 2021
BUY
$4.08 - $5.66 $135,566 - $188,064
33,227 New
33,227 $149,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email